PPH Legal Blog

In the recent trial of three prominent lawyers accused of taking $65 million from their clients’ lawsuit against makers of the diet drug Fen-phen, the defendant Melbourne Mills Jr. was recently hospitalized, delaying the trial.  In addition to the financial theft from their clients’ $200 million settlement, each of the lawyers is also accused of […]

[Read more →]

Now in its second week, the trial for the Fen-phen lawyers continues.  A junior lawyer involved in the settlement, who has testified for four days, says the main lawyers on the case, Cunningham Jr., Gallion, and Mills Jr., never gave the clients a chance to protest the $200 million settlement or the attorney fees.  The […]

[Read more →]

In 2006, Margaret was prescribed phentermine (the “phen” in Fen Phen) to lose weight.  It was a successful drug choice and she quickly lost about 90 lbs.  However, after a year of taking it, Margaret had chest pains and difficulty breathing, complications that landed her in the hospital.  At first, doctors thought she was having […]

[Read more →]

Primary Pulmonary Hypertension (PPH) is a rare and life-threatening lung disease, which results in increased blood pressure in the lungs, creating additional stress on the heart and lungs.  Patients with the disease are often short of breath, dizzy, and lacking energy, because their bodies simply don’t get enough oxygen and are working under extreme pressure.  […]

[Read more →]

Teva Pharmaceutical Industries announced that the Federal Food and Drug Administration approved their new drug application for a generic pulmonary hypertension drug.   Teva’s drug, Epoprostenol, is a version of GlaxoSmithKline’s Flolan for Injection.  Although the drug will not cure pulmonary hypertension, it will help improve the symptoms and quality of life for patients.
During the last […]

[Read more →]